@article{article, title = {{Trastuzumab Emtansine for Treating HER2-Positive, Unresectable, Locally Advanced or Metastatic Breast Cancer After Treatment with Trastuzumab and a Taxane: An Evidence Review Group Perspective of a NICE Single Technology Appraisal}},
publisher = {{Springer Verlag }},
url = {{https://eprints.whiterose.ac.uk/id/eprint/116243 https://doi.org/10.1007/s40273-016-0386-z }},
year = {{2016}},
month = {{7}},
author = {{Squires H and Stevenson M and Simpson E and Harvey R and Stevens J}},
doi = {{10.1007/s40273-016-0386-z}},
volume = {{34}},
journal = {{PharmacoEconomics}},
issue = {{7}},
pages = {{673-680}},
note = {{Accessed on 2025/05/07}}}